NORTHX BIOLOGICS
LIVE

Serial Number

79380258

Owner

NorthX Biologics Matfors AB

Attorney

Alexander Lazouski

Filing Date

Aug 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NORTHX BIOLOGICS Trademark

Serial Number: 79380258 • Registration: 7876941

NORTHX BIOLOGICS is a trademark filed by NorthX Biologics Matfors AB on August 14, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

NorthX Biologics Matfors AB (2 trademarks)

Storjordenvägen 2

Entity Type: 98

NorthX Biologics AB (3 trademarks)

Storjordenvägen 2

Entity Type: 99

Trademark Details

Filing Date

August 14, 2023

Registration Date

August 5, 2025

Published for Opposition

June 17, 2025

Goods & Services

Product research and development; new product analytical development; research and development in the pharmaceutical and biotechnology fields; research and development in the field of microorganisms and cells; research and development for the pharmaceutical industry; biochemical research and development; research services for the development of new pharmaceutical products and advanced therapy product processes; research and development of vaccines and medicines; research and development in the field of diagnostic preparations; development of new products being biological drugs and advanced therapy product processes; medical research laboratory services; research on the subject of pharmaceuticals; provision of information and data relating to medical preparation research and development; scientific research services, and technology advisory services related to pharmaceutical research and development, development of gene therapy products, and genetic biologic products; product research and development in the field of cell banking; product research and development in the field of plasmid DNA production; product research and development in the field of DNA sequencing; medical and scientific research, namely, conducting clinical trials for others; medical and scientific research, namely, conducting clinical trials for others for pharmaceutical products; scientific and medical research on cell banks.

Chemicals used in industry and science, especially proteins, enzymes and modifications thereof

Diagnostic preparations for pharmaceutical purposes; a full line of medicinal products; biological preparations for medical purposes; chemical preparations for medical purposes; diagnostic preparations for medical purposes; biological reagents for medical use; somatic cell therapy products, namely, muscle cells, blood cells, skin cells and nerve cells for medical use; pharmaceutical preparations for gene therapy use, namely, virus, viral vector, and plasmid DNA material to be used in gene therapy applications for medical purposes; cell-based preparations, namely, plasmid DNA and mRNA cell therapy for medical purposes; nucleic acid preparations being nucleic acid sequences for medical purposes; vaccines; recombinant proteins arrays for medical diagnosis purposes; therapeutic antibodies for medical purposes; microbial expressed protein arrays for medical diagnosis purposes; DNA vaccines; DNA plasmids being vaccines and pharmaceutical preparations for use in gene therapies

Scientific apparatus and instruments being medical laboratory research instruments for controlling, measuring, accelerating, and transporting chemicals for use in biochemical and genetic research; Scientific apparatus and instruments, namely, apparatus and instruments being medical laboratory research instruments for use in gene therapy, plasmid DNA production, cell banking and DNA sequencing

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 5, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 13, 2026 FICS
FINAL DISPOSITION PROCESSED
Feb 13, 2026 FIMP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 11, 2025 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Nov 27, 2025 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 26, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 26, 2025 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Nov 26, 2025 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 26, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 26, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 26, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 26, 2025 COAR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 5, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Aug 5, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Aug 5, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 17, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 17, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jun 11, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 13, 2025 TROA
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 24, 2025 GEAN
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Apr 24, 2025 GEAP
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
Apr 24, 2025 EPEN
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Apr 24, 2025 CPEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 27, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 27, 2025 ERFR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Mar 22, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 4, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 4, 2025 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 7, 2024 GNFN
FINAL REFUSAL E-MAILED
Oct 7, 2024 GNFR
FINAL REFUSAL WRITTEN
Oct 7, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 20, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 20, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 20, 2024 TROA
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 2, 2024 ADCH
REFUSAL PROCESSED BY IB
May 22, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 28, 2024 RFCS
REFUSAL PROCESSED BY MPU
Apr 28, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 17, 2024 RFCR
NON-FINAL ACTION WRITTEN
Apr 16, 2024 CNRT
ASSIGNED TO EXAMINER
Apr 15, 2024 DOCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 21, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 21, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 21, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 21, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 21, 2023 COAR
APPLICATION FILING RECEIPT MAILED
Oct 17, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 12, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 5, 2023 REPR